• UTMB Awarded Project Agreement Up to $24.7M from the U.S. Department of Defense to Develop mRNA Vaccines to Prevent Biological Threat Agent Diseases

    UTMB has been awarded an agreement up to nearly $25 million from the U.S. Department of Defense’s (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) (within the Administration for Strategic Preparedness and Response (ASPR)), for their efforts in the collaborative development of vaccines to protect against infection by Ebola (EBOV), Sudan (SUDV), Marburg (MARV), and Lassa (LASV) viruses. This project award was executed via Other Transaction Authority (OTA) to UTMB through the Medical CBRN Defense Consortium (MCDC).

  • UTMB research links COVID-19 pandemic to poor mental health in adolescents

    A new University of Texas Medical Branch study links COVID-19 restrictions to poor mental health in adolescents. “While it was necessary to prevent the pre-vaccine spread of COVID-19, removing children from school was not without consequences,” said Dr. Jeff Temple, Vice Dean for research at UTMB’s School of Nursing and the director of the Center for Violence Prevention. Temple is the lead author of the study published in the Journal of Adolescent Health.

  • An image of a pill capsule full of gears

    UTMB drug discovery partnership awarded $56 million grant

    Thanks to a $56 million grant, the University of Texas Medical Branch and global health care company Novartis will enhance their work together to discover drugs to fight off the next pandemic. The grant comes from the National Institute of Allergy and Infectious Diseases (NIAID) and is one of nine such grants awarded by NIAID to establish Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

  • A group of people place their hands one on top of the other

    UTMB Unveils School of Public and Population Health

    Focused on training the next generation of public health workforce and improving the overall health and well-being of residents, the University of Texas Medical Branch is announcing its newly established School of Public and Population Health today.

  • UTMB Scientists Develop a Vaccine Against Nipah Virus

    Scientists at the University of Texas Medical Branch have developed a vaccine showing promising protection against Nipah virus, a zoonotic virus that has a mortality rate as high as 70 percent and that is considered to be a pathogen of pandemic potential. The study was published in Proceedings of the National Academy of Sciences.

  • UTMB to Name Medical School to recognize $1 billion donor

    The University of Texas Medical Branch is naming its School of Medicine the John Sealy School of Medicine in honor of the 19th century Texas entrepreneur and philanthropist John Sealy and the foundation that was established decades after his death to continue his legacy of support. Over the past 100 years, The Sealy & Smith Foundation has contributed more than $1 billion to UTMB, one of the largest cumulative contributions in history to an American institution.